63
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Is Ki67 a marker for the transformation of laryngeal dysplasia to carcinoma?

, , &
Pages 418-421 | Published online: 26 Aug 2009
 

Abstract

Conclusion. Ki67 is not a reliable marker of malignant transformation in laryngeal dysplasia.

Objectives. No reliable means of predicting which cases of laryngeal dysplasia will undergo malignant transformation currently exists. Our aim was to evaluate Ki67, a marker of cell proliferation, as a potential marker for the transformation of laryngeal dysplasia to squamous cell carcinoma.

Patients and methods. Eighty consecutive cases of previously untreated patients with a histological diagnosis of laryngeal dysplasia from 1987 to 1993 were identified from the pathological archives. Standard immunohistochemical techniques were used to identify Ki67-positive cells and activity was scored on a scale of 0–4 using defined criteria.

Results. Of the 80 cases there were 24 females and 56 males with a mean age of 56 years (range 29–80 years). Twenty cases subsequently transformed to a squamous cell carcinoma. For each Ki67 score (0–4), the rate of malignant transformation was: 0, 1 of 6 patients (17%); 1, 7 of 33 patients (21%); 2, 5 of 22 patients (23%); 3, 4 of 13 patients (31%); and 4, 3 of 6 patients (50%). A higher Ki67 score seemed to correlate with a higher likelihood of malignant transformation but this did not reach statistical significance (p = 0.17, Pearson χ2 test). Considering a score of 3 or 4 as positive for predicting malignant transformation produced a test of relatively high specificity (80%) but poor sensitivity (35%).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.